eCancerTrials
eCancerTrials
National Clinical Trials Database

Welcome to the eCancerTrials.com National Cancer Clinical Trials Database. When you or a loved one are diagnosed with cancer, knowing every treatment option available is your first step in receiving the most complete care. Your treatment plan may include choosing to participate in a cancer clinical trial. Clinical trials in cancer are research studies designed to evaluate new cancer treatment, management, and prevention options. Clinical trials conducted with cancer patients evaluate the safety and effectiveness of new or modified cancer treatment strategies. New anticancer drugs, unique approaches to surgery and radiation therapy are used as well as various combinations of cancer treatments.

Many medical professionals encourage those diagnosed with cancer to at least consider participating in a clinical trial in addition to other treatment options. Furthermore, many treatment options for cancer patients are only available through clinical trials, making participation in a trial the only way to access certain therapies. So if you are not evaluating potential cancer treatments accessible through the clinical trials process alongside current standard therapies, you're not weighing all of your available options.

Although there is currently no single, comprehensive source of available clinical trials, eCancerTrials.com’s provides information on more than 2,000 clinical trials being conducted by leading cancer researchers from all 50 states. These clinical trials evaluate novel treatment approaches and new cancer drugs in all major cancer types, including breast cancer, colon cancer, prostate cancer, lung cancer, lymphoma, leukemia, and many others.

eCancerTrials.com is a free and confidential cancer clinical trials matching and referral service. This resource is provided to cancer patients and their caregivers by leading cancer information specialists at CancerConsultants.com. Interested patients and their advocates may use this resource to:

  • Search—free of charge—for clinical trials applicable to your situation.
  • Search without sharing personal information until you find a trial that is appropriate. At this point you can directly call or e-mail the cancer clinic or center conducting the trial. In this manner your privacy is respected and ensured.
  • eCancerTrials.com provides interested patients and their family members with additional services to help locate appropriate clinical trials.

Use the search engine below to look for clinical trials, or learn more about clinical trials.

Search by cancer type:
 
Filter by:


U.S. Regional Map Northwest Southwest Midwest Southeast Northeast
Displaying clinical trials in "Thyroid Cancer" in "All cancer stages" in "All States":
Protocol No. Title
REFMAL28-T A PHASE I STUDY OF ORAL TEMOZOLOMIDE IN COMBINATION WITH IRINOTECAN IN PATIENT WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS.-T
REFMAL30-T A PHASE I, OPEN-LABEL, MULTI-DOSE, DOSE-ESCALATION STUDY OF GW572016 IN PATIENTS WITH SOLID TUMORS-T
REFMAL39 A Phase I, Open-Label, Dose-Escalation Study of SB-715992 Administered Weekly for Three Consecutive Weeks of 28-Day Cycle in Patients with Solid Tumors
Bayer14295 A Double-Blind, Randomized Phase III Study Evaluating the Efficacy and Safety of Sorafenib Compared to Placebo in Locally Advanced/Metastatic RAI-Refractory Differentiated Thyroid Cancer
REFMAL31 A STUDY TO DETERMINE THE BIOEQUIVALENCE OF AN ORAL FORMULATION OF TOPOTECAN CONTAINING THE DRUG SUBSTANCE MANUFACTURED BY NEW PROCESS RELATIVE TO THE CURRENT STUDY FORMULATION OF TOPOTECAN IN PATIENTS WITH ADVANCED SOLID TUMORS
REFMAL32 AN OPEN-LABEL, SAFETY, PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF MULTIPLE DOSES OF GW572016 TO EXAMINE THE INHIBITION OF EGFR/ERBB-2 PHOSPHORYLATION IN CANCER PATIENTS WITH SOLID TUMORS
REFMAL33 A PHASE I TRIAL OF WEEKLY AMONAFIDE (AMF)IN PATIENTS WITH ADVANCED, SOLID TUMORS
REFMAL34 A PHASE I STUDY OF TOPOTECAN IN COMBINATION WITH DOCETAXEL IN PATIENTS WITH REFRACTORY AND/OR ADVANCED SOLID TUMORS
E-5-05 Phase II Study of Decitabine in Patients with Metastatic Papillary Thyroid Cancer of Follicular Thyroid Cancer Unresponsive to Radioiodine.
REFMAL29-Th A PHASE I STUDY TO DETERMINE THE SAFETY AND PHARMACOKINETICS OF BMS-387032 GIVEN EVERY THREE WEEKS IN PATIENTS WITH METASTATIC REFRACTORY SOLID TUMORS-Th